SCHEMBL28987474

SCHEMBL28987474

COCCN(CCC(=O)O)Cc1ccc(OC)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.53
TSHR P16473 1/20 0.53
MEP1B Q16820 3/20 0.51
FFAR1 O14842 2/20 0.47
KDM4E B2RXH2 2/20 0.45
F2RL1 P55085 1/20 0.45
ACHE P22303 2/20 0.45
ALDH1A1 P00352 2/20 0.44
HTT P42858 2/20 0.44
MEP1A Q16819 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NR1H3 Q13133 1/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
BCHE P06276 1/20 0.44
POLB P06746 1/20 0.43
SIGMAR1 Q99720 1/20 0.43
OPRK1 P41145 1/20 0.43
PDE4B Q07343 1/20 0.43
ALOX12 P18054 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27200631 0.90 MEP1B (0.60) USP2TSHRMEP1BFFAR1KDM4E
SCHEMBL28182017 0.87 MEP1B (0.52) USP2TSHRMEP1BFFAR1KDM4E
SCHEMBL25489028 0.84 LTA4H (0.46) USP2TSHRMEP1BKDM4EACHE
SCHEMBL9172532 0.81 MEP1B (0.58) USP2TSHRMEP1BFFAR1ACHE
SCHEMBL9540871 0.79 ACHE (0.56) USP2TSHRMEP1BFFAR1ACHE
SCHEMBL21665226 0.79 HDAC8 (0.47) TSHRMEP1BFFAR1ALDH1A1HTT
SCHEMBL18646559 0.79 TSHR (0.62) USP2TSHRMEP1BFFAR1KDM4E
SCHEMBL23857640 0.79 MEP1B (0.58) MEP1BKDM4EF2RL1ACHEALDH1A1
SCHEMBL17230510 0.79 TSHR (0.49) TSHR
SCHEMBL25488930 0.78 NR1D1 (0.47) USP2TSHRMEP1BKDM4EACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115996927-A Pyrimido [5,4-d ] pyrimidine derivatives and combinations with adenosine receptor antagonists as ENT inhibitors for the treatment of cancer ITEOS比利时公司 2023-04-21 CN disclosed